Literature DB >> 26181512

Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates.

Katrine Kielsen1,2, Zaiba Shamim1,2, Lars P Ryder3, Flemming Nielsen4, Philippe Grandjean4,5, Esben Budtz-Jørgensen6, Carsten Heilmann1.   

Abstract

Recent studies suggest that exposure to perfluorinated alkylate substances (PFASs) may induce immunosuppression in humans and animal models. In this exploratory study, 12 healthy adult volunteers were recruited. With each subject, serum-PFAS concentrations were measured and their antibody responses prospectively followed for 30 days after a booster vaccination with diphtheria and tetanus. The results indicated that serum-PFAS concentrations were positively correlated and positively associated with age and male sex. The specific antibody concentrations in serum were increased from Day 4 to Day 10 post-booster, after which a constant concentration was reached. Serum PFAS concentrations showed significant negative associations with the rate of increase in the antibody responses. Interestingly, this effect was particularly strong for the longer-chain PFASs. All significant associations remained significant after adjustment for sex and age. Although the study involved a small number of subjects, these findings of a PFAS-associated reduction of the early humoral immune response to booster vaccination in healthy adults supported previous findings of PFAS immunosuppression in larger cohorts. Furthermore, the results suggested that cellular mechanisms right after antigen exposure should be investigated more closely to identify possible mechanisms of immunosuppression from PFAS.

Entities:  

Keywords:  Antibodies; immunotoxicity; perfluorinated alkylate substances; prospective study; vaccinations

Mesh:

Substances:

Year:  2015        PMID: 26181512      PMCID: PMC4739630          DOI: 10.3109/1547691X.2015.1067259

Source DB:  PubMed          Journal:  J Immunotoxicol        ISSN: 1547-691X            Impact factor:   3.000


  10 in total

1.  Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.

Authors:  Philippe Grandjean; Elisabeth Wreford Andersen; Esben Budtz-Jørgensen; Flemming Nielsen; Kåre Mølbak; Pal Weihe; Carsten Heilmann
Journal:  JAMA       Date:  2012-01-25       Impact factor: 56.272

2.  Changing interpretation of human health risks from perfluorinated compounds.

Authors:  Philippe Grandjean; Richard Clapp
Journal:  Public Health Rep       Date:  2014 Nov-Dec       Impact factor: 2.792

3.  In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs).

Authors:  Emanuela Corsini; Enrico Sangiovanni; Anna Avogadro; Valentina Galbiati; Barbara Viviani; Marina Marinovich; Corrado L Galli; Mario Dell'Agli; Dori R Germolec
Journal:  Toxicol Appl Pharmacol       Date:  2011-11-18       Impact factor: 4.219

Review 4.  Immunotoxicity of perfluorinated compounds: recent developments.

Authors:  Jamie C DeWitt; Margie M Peden-Adams; Jennifer M Keller; Dori R Germolec
Journal:  Toxicol Pathol       Date:  2011-11-22       Impact factor: 1.902

5.  Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008.

Authors:  Kayoko Kato; Lee-Yang Wong; Lily T Jia; Zsuzsanna Kuklenyik; Antonia M Calafat
Journal:  Environ Sci Technol       Date:  2011-04-06       Impact factor: 9.028

6.  Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.

Authors:  Claire Looker; Michael I Luster; Antonia M Calafat; Victor J Johnson; Gary R Burleson; Florence G Burleson; Tony Fletcher
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

Review 7.  Developmental immunotoxicology: focus on health risks.

Authors:  Rodney R Dietert
Journal:  Chem Res Toxicol       Date:  2009-01       Impact factor: 3.739

8.  Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.

Authors:  Berit Granum; Line S Haug; Ellen Namork; Solvor B Stølevik; Cathrine Thomsen; Ingeborg S Aaberge; Henk van Loveren; Martinus Løvik; Unni C Nygaard
Journal:  J Immunotoxicol       Date:  2013-01-25       Impact factor: 3.000

9.  A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring.

Authors:  Line Småstuen Haug; Cathrine Thomsen; Georg Becher
Journal:  J Chromatogr A       Date:  2008-11-05       Impact factor: 4.759

10.  Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice.

Authors:  Deborah E Keil; Tracey Mehlmann; Leon Butterworth; Margie M Peden-Adams
Journal:  Toxicol Sci       Date:  2008-02-05       Impact factor: 4.849

  10 in total
  24 in total

1.  Serum perfluoroalkyl acids (PFAAs) and associations with behavioral attributes.

Authors:  Rebecca Siebenaler; Rochelle Cameron; Craig M Butt; Kate Hoffman; Christopher P Higgins; Heather M Stapleton
Journal:  Chemosphere       Date:  2017-06-09       Impact factor: 7.086

2.  Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.

Authors:  Philippe Grandjean; Carsten Heilmann; Pal Weihe; Flemming Nielsen; Ulla B Mogensen; Amalie Timmermann; Esben Budtz-Jørgensen
Journal:  J Immunotoxicol       Date:  2017-12       Impact factor: 3.000

3.  Children's white blood cell counts in relation to developmental exposures to methylmercury and persistent organic pollutants.

Authors:  Y Oulhote; Z Shamim; K Kielsen; P Weihe; P Grandjean; L P Ryder; C Heilmann
Journal:  Reprod Toxicol       Date:  2016-08-04       Impact factor: 3.143

Review 4.  Immunomodulation and exposure to per- and polyfluoroalkyl substances: an overview of the current evidence from animal and human studies.

Authors:  Evangelia Antoniou; Thomas Colnot; Maurice Zeegers; Wolfgang Dekant
Journal:  Arch Toxicol       Date:  2022-06-13       Impact factor: 6.168

5.  Environmental exposures are hidden modifiers of anti-viral immunity.

Authors:  Anthony M Franchini; B Paige Lawrence
Journal:  Curr Opin Toxicol       Date:  2018-01-31

6.  Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults.

Authors:  Cheryl R Stein; Yongchao Ge; Mary S Wolff; Xiaoyun Ye; Antonia M Calafat; Thomas Kraus; Thomas M Moran
Journal:  Environ Res       Date:  2016-05-18       Impact factor: 6.498

Review 7.  A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans.

Authors:  Ellen T Chang; Hans-Olov Adami; Paolo Boffetta; H James Wedner; Jack S Mandel
Journal:  Crit Rev Toxicol       Date:  2016-01-13       Impact factor: 5.635

8.  Translatability and transferability of in silico models: Context of use switching to predict the effects of environmental chemicals on the immune system.

Authors:  Francesco Pappalardo; Giulia Russo; Emanuela Corsini; Alicia Paini; Andrew Worth
Journal:  Comput Struct Biotechnol J       Date:  2022-03-26       Impact factor: 6.155

9.  Cross-sectional associations between serum PFASs and inflammatory biomarkers in a population exposed to AFFF-contaminated drinking water.

Authors:  Kelsey E Barton; Lauren M Zell-Baran; Jamie C DeWitt; Stephen Brindley; Carrie A McDonough; Christopher P Higgins; John L Adgate; Anne P Starling
Journal:  Int J Hyg Environ Health       Date:  2022-01-19       Impact factor: 7.401

10.  Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.

Authors:  Philippe Grandjean; Carsten Heilmann; Pal Weihe; Flemming Nielsen; Ulla B Mogensen; Esben Budtz-Jørgensen
Journal:  Environ Health Perspect       Date:  2017-07-26       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.